Physician profile
Michael T Nesbit
NPI 1689785982
$456.41
in general payments reported to CMS, 2019-2025
12 companies · $105 in 2025
The $105 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.27 · 2020: $16.40 · 2021: $115 · 2022: $38.52 · 2023: $63.73 · 2024: $78.99 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $248.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $99.68 | 2021 | |
| Abbvie INC. | $81.08 | 2025 | |
| Abbott Laboratories | $80.72 | 2022-2025 | Eterna, Proclaim |
| Medtronic, INC. | $56.63 | 2023-2024 | Intellis Adaptivestim |
| Pacira Pharmaceuticals Incorporated | $30.64 | 2024 | Exparel, Iovera |
| Takeda Pharmaceuticals U.S.A., INC. | $20.74 | 2023 | Entyvio |
| Heron Therapeutics, INC. | $16.74 | 2024 | Aponvie |
| Collegium Pharmaceutical, INC. | $16.40 | 2020 | |
| Si-Bone, INC. | $15.51 | 2021 | |
| Merck Sharp & Dohme LLC | $13.62 | 2019 | |
| Pfizer INC. | $12.84 | 2019 | |
| Medtronic USA, INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nesbit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.